SignatureFD’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

SignatureFD’s Portfolio IDNA Stock Details IDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-1,500	Closed	-$33.9K	–	3370
2024 Q4	$33.9K	Hold	1,500	–	–	﹤0.01%	1776
2024 Q3	$36.9K	Hold	1,500	–	–	﹤0.01%	1746
2024 Q2	$34.7K	Hold	1,500	–	–	﹤0.01%	1695
2024 Q1	$36.1K	Hold	1,500	–	–	﹤0.01%	1711
2023 Q4	$34.5K	Hold	1,500	–	–	﹤0.01%	1655
2023 Q3	$30.5K	Hold	1,500	–	–	﹤0.01%	1634
2023 Q2	$35K	Hold	1,500	–	–	﹤0.01%	1611
2023 Q1	$34.9K	Hold	1,500	–	–	﹤0.01%	1571
2022 Q4	$37.8K	Hold	1,500	–	–	﹤0.01%	1489
2022 Q3	$40K	Hold	1,500	–	–	﹤0.01%	1385
2022 Q2	$43K	Hold	1,500	–	–	﹤0.01%	1376
2022 Q1	$52K	Hold	1,500	–	–	﹤0.01%	1351
2021 Q4	$66K	Buy	1,500 +900	+150%	+$42.6K	﹤0.01%	1211
2021 Q3	$30K	Buy	+600	New	+$31.3K	﹤0.01%	1556

Other funds holding IDNA

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

CCA

Clearwater Capital Advisors Hoffman Estates, Illinois $1.24B AUM 15.23% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Lido Advisors Los Angeles, California $32.7B AUM 19.2% 1-Year Est. Return

CCA

Cora Capital Advisors Marlton, New Jersey $302M AUM 16.46% 1-Year Est. Return

SignatureFD's IDNA Position: Q1 2025 in Review

SignatureFD sold out of iShares Genomics Immunology and Healthcare ETF (IDNA) in Q1 2025, closing a stake of 1,500 shares — an estimated $33.9K sold.

SignatureFD first reported a position in IDNA in Q3 2021 and held it in 14 quarters. The position peaked at $66K in Q4 2021. 48 funds tracked by Wall St. Rank hold IDNA as of Q1 2025.

SignatureFD reported no remaining iShares Genomics Immunology and Healthcare ETF position as of Q1 2025 after selling out during the quarter.
SignatureFD sold 1,500 iShares Genomics Immunology and Healthcare ETF shares in Q1 2025, an estimated $33.9K.
SignatureFD first reported a position in iShares Genomics Immunology and Healthcare ETF in Q3 2021 and held it in 14 quarters.
SignatureFD's iShares Genomics Immunology and Healthcare ETF position peaked at $66K in Q4 2021.
48 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q1 2025.

Based on SignatureFD's 13F filing for Q1 2025, filed 2 May 2025.